Additionally, through further immunoblot analysis of tumor tissues, we observed that Formononetin treatment led to a reduction in the expression of intracellular ferroptosis-related proteins GPX4, and xCT (Figure 2K). This evidence concerns the gene GPX4 and neoplasm.